ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
119.815,41
0,16%
S&P 500
5.918,25
0,00%
US Dollar vs BRL
6,0796
-0,45%
Bitcoin
92.742,49
-2,44%
Brent Oil
76,445
0,60%
As Melhores Corretoras Online
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Bicycle Therapeutics PLC (BCYC)

  7. Bicycle Therapeutics PLC (BCYC) Notícias

BCYC

Bicycle Therapeutics (BCYC)

Bicycle Therapeutics PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BCYC
DataHoraFonteTítuloCódigoCompanhia
09/01/202509:00Business WireBicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:BCYCBicycle Therapeutics PLC
06/01/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
06/01/202514:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
03/01/202518:05Business WireBicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BCYCBicycle Therapeutics PLC
19/12/202417:47Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BCYCBicycle Therapeutics PLC
13/12/202411:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCYCBicycle Therapeutics PLC
12/12/202420:30Business WireBicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene AmplificationNASDAQ:BCYCBicycle Therapeutics PLC
10/12/202409:00Business WireBicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology ExpertsNASDAQ:BCYCBicycle Therapeutics PLC
25/11/202419:30Business WireBicycle Therapeutics to Present Data for Zelenectide Pevedotin at 2024 San Antonio Breast Cancer Symposium and Provide Program UpdateNASDAQ:BCYCBicycle Therapeutics PLC
14/11/202418:32Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BCYCBicycle Therapeutics PLC
12/11/202409:00Business WireBicycle Therapeutics to Participate in the Jefferies London Healthcare ConferenceNASDAQ:BCYCBicycle Therapeutics PLC
31/10/202408:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCYCBicycle Therapeutics PLC
31/10/202408:00Business WireBicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial ResultsNASDAQ:BCYCBicycle Therapeutics PLC
23/10/202408:00Business WireBicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation RadiopharmaceuticalsNASDAQ:BCYCBicycle Therapeutics PLC
16/10/202408:00Business WireBicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 CongressNASDAQ:BCYCBicycle Therapeutics PLC
14/09/202404:00Business WireBicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024NASDAQ:BCYCBicycle Therapeutics PLC
21/08/202408:00Business WireBicycle Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BCYCBicycle Therapeutics PLC
06/08/202418:00Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BCYCBicycle Therapeutics PLC
06/08/202408:05Business WireBicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial ResultsNASDAQ:BCYCBicycle Therapeutics PLC
22/07/202408:00Business WireBicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024NASDAQ:BCYCBicycle Therapeutics PLC
18/06/202417:14Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:BCYCBicycle Therapeutics PLC
23/05/202418:05Business WireBicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual MeetingNASDAQ:BCYCBicycle Therapeutics PLC
23/05/202408:00Business WireBicycle Therapeutics Announces $555 Million Private Placement Equity FinancingNASDAQ:BCYCBicycle Therapeutics PLC
02/05/202408:00Business WireBicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial ResultsNASDAQ:BCYCBicycle Therapeutics PLC
24/04/202411:05Business WireBicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual MeetingNASDAQ:BCYCBicycle Therapeutics PLC
02/04/202408:00Business WireBicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:BCYCBicycle Therapeutics PLC
05/03/202418:35Business WireBicycle Therapeutics to Present at the AACR Annual Meeting 2024NASDAQ:BCYCBicycle Therapeutics PLC
21/02/202418:40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
20/02/202409:19Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BCYCBicycle Therapeutics PLC
20/02/202409:05Business WireBicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BCYCBicycle Therapeutics PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:BCYC

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PMAM3
PARANAPANEMA ON
BOV
AZEV4
AZEVEDO PN
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
FICT3
Fictor Alimentos ON
BOV
ELET3
ELETROBRAS ON
BOV
GOLL4
GOL PN
BOV
CSAN3
COSAN ON
BOV
PRIO3
PETRORIO ON
BOV
TECN3
TECHNOS ON
BOV
AERI3
Aeris Industria E Comerc... ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
COCE5
COELCE PNA
BOV
BHIA3
Grupo Casas Bahia ON
BOV
MNPR3
MINUPAR ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados